Stage IIIB Skin Melanoma Completed Phase Trials for Benzalkonium (DB11105)

IndicationStatusPhase
DBCOND0029534 (Stage IIIB Skin Melanoma)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01460875Recombinant Interferon Alfa-2b in Treating Patients With MelanomaTreatment